Sulfated polymannuroguluronate

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSulfated polymannuroguluronate
Drug Alias NameSPMG
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionEnvelope glycoprotein gp160 agonistsTubulin agonists
TargetsEnvelope glycoprotein gp160Tubulin
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOcean University Of ChinaOcean University Of China Lantai Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOcean University Of China Lantai Pharmaceutical Co LtdOcean University Of China
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A